BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16836756)

  • 1. Comparison of lentiviral vector titration methods.
    Geraerts M; Willems S; Baekelandt V; Debyser Z; Gijsbers R
    BMC Biotechnol; 2006 Jul; 6():34. PubMed ID: 16836756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
    Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
    Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of lentiviral vectors for transducing cells from the central nervous system.
    Li M; Husic N; Lin Y; Snider BJ
    J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative polymerase chain reaction as a reliable method to determine functional lentiviral titer after ex vivo gene transfer in human mesenchymal stem cells.
    Böcker W; Rossmann O; Docheva D; Malterer G; Mutschler W; Schieker M
    J Gene Med; 2007 Jul; 9(7):585-95. PubMed ID: 17510916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid and efficient branched DNA hybridization assay to titer lentiviral vectors.
    Nair A; Xie J; Joshi S; Harden P; Davies J; Hermiston T
    J Virol Methods; 2008 Nov; 153(2):269-72. PubMed ID: 18706449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal real-time PCR-based assay for lentiviral titration.
    Barczak W; Suchorska W; Rubiś B; Kulcenty K
    Mol Biotechnol; 2015 Feb; 57(2):195-200. PubMed ID: 25370825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells.
    Xu Z; Chen F; Zhang L; Lu J; Xu P; Liu G; Xie X; Mu W; Wang Y; Liu D
    Sci China Life Sci; 2016 Oct; 59(10):1024-1033. PubMed ID: 27614752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1-based lentiviral vectors.
    Liu YP; Berkhout B
    Methods Mol Biol; 2014; 1087():273-84. PubMed ID: 24158830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel bovine lentiviral vectors based on Jembrana disease virus.
    Metharom P; Takyar S; Xia HH; Ellem KA; Macmillan J; Shepherd RW; Wilcox GE; Wei MQ
    J Gene Med; 2000; 2(3):176-85. PubMed ID: 10894263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of lentiviral vectors in protein-free media.
    Kuroda H; Marino MP; Kutner RH; Reiser J
    Curr Protoc Cell Biol; 2011 Mar; Chapter 26():Unit 26.8. PubMed ID: 21400699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
    Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
    Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable Expression by Lentiviral Transduction of Cells.
    Gödecke N; Hauser H; Wirth D
    Methods Mol Biol; 2018; 1850():43-55. PubMed ID: 30242679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the titer and infectivity of lentiviral vectors.
    Logan AC; Nightingale SJ; Haas DL; Cho GJ; Pepper KA; Kohn DB
    Hum Gene Ther; 2004 Oct; 15(10):976-88. PubMed ID: 15585113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time quantitative PCR for the design of lentiviral vector analytical assays.
    Delenda C; Gaillard C
    Gene Ther; 2005 Oct; 12 Suppl 1():S36-50. PubMed ID: 16231054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-on polyadenylation strategy as a supplemental mechanism for silencing toxic transgene expression during lentiviral vector production.
    Bagnis C; Zwojsczyki G; Chiaroni J; Bailly P
    Biotechniques; 2014 Jun; 56(6):311-2, 314-8. PubMed ID: 24924391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.
    Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A
    Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of plasmid DNA removal from lentiviral vectors by benzonase treatment.
    Sastry L; Xu Y; Cooper R; Pollok K; Cornetta K
    Hum Gene Ther; 2004 Feb; 15(2):221-6. PubMed ID: 14975194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized Transgene Delivery Using Third-Generation Lentiviruses.
    Gill KP; Denham M
    Curr Protoc Mol Biol; 2020 Dec; 133(1):e125. PubMed ID: 32986282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
    ter Brake O; Berkhout B
    J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.